Biotech Values

[DewDiligence]

Re: MYGN

>>In the clinic, they have an enantiomer of flurbiprofen for alzheimer's disease. Because of my lack of knowledge in the CNS area, I have no substantive comments on this drug's chances, or lack thereof.<<

I’ve always considered it odd that MYGN had a single compound being tested for both Alzheimer’s and prostate cancer. I also tend to be suspicious of attempts to resuscitate a mediocre racemic drug by going to a single isomer.

Earlier this year, MYGN could have been bought for the value of the diagnostic business alone (#msg-3849780). Not true now.